Fingerprint
Dive into the research topics of 'Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically